26 h. ago COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announces further to its news release of March 19, 2025 (the “Default Announcement”) that its application to the […]

Economics

49 h. ago Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order

Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 2 weeks TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announces that it will miss the […]

Economics

5 d. ago Calibre Mining Announces Receipt of Interim Order and Filing and Mailing of Meeting Materials for Special Meeting of Securityholders in Connection With the Business Combination With Equinox Gold

Your vote is important no matter how many Calibre shares and stock options you hold. The Board of Directors of Calibre recommends that Calibre Securityholders vote FOR the Arrangement Resolution. For assistance in voting, please contact Laurel Hill Advisory Group by phone at 1-877-452-7184 (toll-free in North America) or 1-416-304-0211 (collect, international), or by email […]

Economics

6 d. ago Westaim Announces Receipt of Required Regulatory Approvals in Connection with CC Capital Transaction

TORONTO — The Westaim Corporation (“Westaim” or the “Company”) (TSXV: WED) is pleased to announce that, in connection with its previously announced proposed transaction with CC Capital Partners, LLC (the “Transaction”), all regulatory approvals necessary to complete the Transaction under the terms of the investment agreement entered into between, among others, the Company and Wembley […]

Economics

9 d. ago WillScot Announces Expiration of Consent Solicitations and Receipt of Consents to Amend its Senior Secured Notes due 2029 and Senior Secured Notes due 2031

PHOENIX, March 24, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, announced the expiration and results of the previously announced Consent Solicitations of its indirect subsidiary, Williams Scotsman, Inc. (“WSI”), soliciting consents (“Consents”) from holders of its existing 6.625% Senior Secured Notes due […]

Other

1 week ago Electra Announces Federal Government Support for Completion of North America’s Only Cobalt Sulfate Refinery

(All amounts in $C unless otherwise specified) TORONTO, March 21, 2025 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) is pleased to announce receipt of a Letter of Intent (“LOI”) for proposed funding of $20 million. The funding will support completion of construction and commissioning of North America’s […]

Politics

2 w. ago COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year

TORONTO, ONTARIO, March 19, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced that there is a potential for delay in the filing of: (a) its annual financial statements as […]

Other

2 w. ago COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti

No significant clinical adverse event observed in Phase 1clinical study Pharmacokinetic profile established and range of doses selected for Phase 2a Clinical Efficacy Study First patient expected to be treated in the Phase 2a Clinical Efficacy Study on March 14, 2025 at the Montreal Heart Institute TORONTO, ONTARIO, March 13, 2025 (GLOBE NEWSWIRE) — COSCIENS […]

Other

3 w. ago Gold Bull Announces Shareholder Approval, Receipt of Court Approval and Expected Closing Date of Borealis Arrangement

VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) — Gold Bull Resources Corp. (TSXV: GBRC) (“Gold Bull”) is pleased to announce that Gold Bull shareholders (“Shareholders”) approved the plan of arrangement (the “Arrangement”) with Borealis Mining Company Limited (“Borealis”) at the annual general and special meeting held on February 28, 2025 (the “Meeting”). At the […]

Other

4 w. ago Spark Biomedical Receives Health Canada’s Medical Device License for Sparrow Ascent Opioid Withdrawal Treatment

New Health Canada Approval Allows Spark Biomedical to Offer Drug-Free Opioid Withdrawal Relief Across Canada. Dallas, TX, March 05, 2025 (GLOBE NEWSWIRE) — Spark Biomedical, a leader in wearable neurostimulation technology, announces the receipt of its Medical Device License from Health Canada for Sparrow AscentTM, an FDA-cleared non-invasive, drug-free, neurostimulation device for opioid withdrawal. The […]

Economics